A Menthol, trans-1,3,cis-1,4- CEP of the European Pharmacopoeia monograph is often referred to as a Menthol, trans-1,3,cis-1,4- Certificate of Suitability (COS). The purpose of a Menthol, trans-1,3,cis-1,4- CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Menthol, trans-1,3,cis-1,4- EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Menthol, trans-1,3,cis-1,4- to their clients by showing that a Menthol, trans-1,3,cis-1,4- CEP has been issued for it. The manufacturer submits a Menthol, trans-1,3,cis-1,4- CEP (COS) as part of the market authorization procedure, and it takes on the role of a Menthol, trans-1,3,cis-1,4- CEP holder for the record. Additionally, the data presented in the Menthol, trans-1,3,cis-1,4- CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Menthol, trans-1,3,cis-1,4- DMF.
A Menthol, trans-1,3,cis-1,4- CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Menthol, trans-1,3,cis-1,4- CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Menthol, trans-1,3,cis-1,4- suppliers with CEP (COS) on PharmaCompass.